White matter disease is staged using a 0-to-3 grading system called the Fazekas scale, giving four levels: none, mild, moderate, and severe. Doctors assign the grade based on how white matter lesions appear on a brain MRI. Over 90% of people older than 65 have at least some degree of these white matter changes, and the volume of affected tissue tends to increase with each decade of life.
The Fazekas scale actually rates two regions of the brain separately: the area right around the fluid-filled ventricles in the center of the brain (periventricular) and the deeper white matter farther out. Each region gets its own 0-to-3 score, and the two can be added together for a combined score of 0 to 6. But when people refer to “the four stages,” they’re typically talking about the individual 0-to-3 scale.
How the Staging Works on MRI
White matter lesions show up as bright spots on a specific type of MRI sequence called T2-FLAIR. This imaging technique suppresses the signal from spinal fluid so that abnormal white matter stands out clearly. A radiologist looks at the size, shape, and distribution of those bright spots to assign a Fazekas grade. The process is visual, meaning the doctor compares what they see against standardized reference images rather than measuring exact volumes, though automated software tools are increasingly used to calculate precise lesion volumes.
Stage 0: No Lesions
Stage 0 means the MRI shows no abnormal bright spots in the white matter at all. This is a normal finding and serves as the baseline for comparison. In practice, a completely clean scan becomes less common with age.
Stage 1: Mild, Scattered Spots
At stage 1, the MRI shows small, isolated changes. Around the ventricles, this looks like a pencil-thin line or small caps of brightness at the tips of the ventricles. In the deeper white matter, the lesions appear as tiny punctate dots, each one separate from the others.
Most people at this stage have no noticeable symptoms. The scattered dots represent minor damage to the small blood vessels that supply the brain’s white matter, but the brain has enough redundancy to compensate. Stage 1 findings are extremely common in older adults and are often described on MRI reports as “age-appropriate changes.”
Stage 2: Moderate, Beginning to Merge
Stage 2 marks the point where isolated spots start joining together. Around the ventricles, the thin lining from stage 1 thickens into a smooth halo of brightness. In the deeper white matter, the individual dots begin to clump and fuse, a pattern radiologists call “beginning confluence.”
Symptoms at this stage are still often subtle. Some people notice mild difficulties with processing speed or multitasking, functions that depend heavily on the white matter connections between different brain regions. But many people at stage 2 remain cognitively normal, and the changes may only be caught incidentally on an MRI done for another reason.
Stage 3: Severe, Large Fused Areas
At stage 3, the damage is extensive. Around the ventricles, the bright signal spreads outward in irregular patches that extend deep into surrounding tissue. In the deeper white matter, the formerly separate dots have merged into large confluent areas of damage.
This stage carries real clinical significance. Cognitive decline, particularly in executive functions like planning and decision-making, becomes more noticeable. Walking and balance problems are common because the white matter tracts that coordinate movement are affected. Research published in the Journal of Cerebral Blood Flow & Metabolism identified a combined Fazekas score of 3 as the critical threshold predicting future cognitive decline, with lesions expanding into the parietal, temporal, and frontal regions of the brain. The pattern supports what researchers call the “disconnection hypothesis,” where damage to white matter pathways isolates brain regions that need to communicate with each other.
How Quickly It Progresses
White matter disease is a chronic condition that tends to accelerate over time. In a large study that followed participants with repeat MRI scans roughly 3.4 years apart, the strongest predictors of progression were the severity of existing lesions and age. In other words, the more damage you already have, the faster new damage accumulates.
High blood pressure and smoking were independently associated with worsening lesions. Interestingly, blood pressure had the greatest impact on progression in people aged 60 to 69 who didn’t yet have severe changes. In the oldest participants (80 to 90) and those who already had extensive disease, blood pressure was no longer a significant driver, suggesting there may be a window where controlling blood pressure matters most. Women showed more marked progression of deep white matter lesions compared to men.
What Drives the Damage
White matter disease is primarily a disorder of the brain’s small blood vessels. These tiny arteries and capillaries become stiffened, narrowed, or leaky over time, reducing blood flow to the white matter. The white matter is particularly vulnerable because it sits in a “watershed” zone, the area farthest from the brain’s main blood supply, where even small reductions in flow can cause damage.
The same risk factors that damage blood vessels elsewhere in the body drive the process in the brain: high blood pressure, diabetes, smoking, and high cholesterol. Of these, high blood pressure is the most consistently linked to progression. Age itself is a major factor, as the small vessels stiffen naturally over decades.
What the Stages Mean for You
If your MRI report mentions white matter changes, the Fazekas grade gives you a snapshot of where things stand. Stages 0 and 1 are common, expected findings in older adults and rarely cause concern on their own. Stage 2 is a signal that the process is active and that managing cardiovascular risk factors, particularly blood pressure, could slow further progression. Stage 3 indicates significant disease that is more likely to affect cognition, mood, and mobility.
The staging doesn’t tell the whole story, though. Where the lesions are located matters as much as how many there are. Lesions in areas that connect the frontal lobes tend to affect planning and processing speed, while lesions near motor pathways are more likely to cause balance issues. Two people with the same Fazekas score can have very different symptoms depending on the specific tracts involved.
Because progression tends to accelerate once it starts, the most impactful time to intervene is early, when lesions are still mild and blood pressure control can make the biggest difference in slowing the disease down.